Wes Kaupinen - President and CEO, Director, 10%+ Owner at Pieris Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director, 10%+ Owner
Stock Symbol
PIRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Wes Kaupinen since 12/22/2023

Holdings reported by Wes Kaupinen for Pieris Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 781K $12.4M $15.88 Dec 13, 2024 by Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019
Common Stock 781K $12.4M $15.88 Dec 13, 2024 by Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019
Common Stock 42.9K $682K $15.88 Dec 13, 2024 Direct
Stock Option (right to buy) 418K Dec 13, 2024 Direct Common Stock

Transactions reported by Wes Kaupinen for Pieris Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.